What does DR. FRANK VERDUYCKT do?

DR. FRANK VERDUYCKT is a specialist medical practice in Tongeren-Borgloon. Private Limited, started on 15 September 2006, 2 establishments.

What is the address of DR. FRANK VERDUYCKT?

The registered office of DR. FRANK VERDUYCKT is located at Mantelstraat 12, 3700 Tongeren-Borgloon.

Is DR. FRANK VERDUYCKT still active?

Yes. According to the CBE (17 September 2026) DR. FRANK VERDUYCKT is active, legal situation “Normale toestand”, started on 15 September 2006.

Is DR. FRANK VERDUYCKT registered on Peppol?

Yes, DR. FRANK VERDUYCKT is registered on the Peppol network with ID 0208:0883663070.

What is the enterprise number of DR. FRANK VERDUYCKT?

The enterprise number of DR. FRANK VERDUYCKT is BE0883663070.

When was DR. FRANK VERDUYCKT founded?

DR. FRANK VERDUYCKT was founded on 15 September 2006.

Who are the directors of DR. FRANK VERDUYCKT?

According to the 2025 annual accounts, the directors of DR. FRANK VERDUYCKT are: Frank Verduyckt.

Is DR. FRANK VERDUYCKT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 September 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. FRANK VERDUYCKT make in 2025?

DR. FRANK VERDUYCKT posted a profit after taxes of € 161,721 in financial year 2025.

What is the revenue of DR. FRANK VERDUYCKT?

As a small company, DR. FRANK VERDUYCKT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 220,356.

DR. FRANK VERDUYCKT (Private Limited) - Tongeren-Borgloon

Dossier DR. FRANK VERDUYCKT, printed on 17 September 2026 from databakkes.be/en/0883663070/dr-frank-verduyckt. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. FRANK VERDUYCKT from Tongeren-Borgloon, company number BE0883663070, closed financial year 2025 with a result of € 161,721 after tax. For that financial year DR. FRANK VERDUYCKT recorded a gross margin of € 220,356 and equity of € 953,982. Compared with financial year 2024, the result moved from € 185,606 to € 161,721. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 953,982

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 161,721

▼ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 345,283

▲ € 263,523 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 810,182.

People and assets in 2025

Vehicles and equipment

€ 4,275

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 10,292

▲ 26% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 57,430

▲ 106% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 139,678 Gross margin 2022: € 139,678 First fiscal year in the series	€ 141,421 Gross margin 2023: € 141,421 ▲ 1% vs 2022 (€ 139,678) Favourable step	€ 251,057 Gross margin 2024: € 251,057 ▲ 78% vs 2023 (€ 141,421) Favourable step	€ 220,356 Gross margin 2025: € 220,356 ▼ 12% vs 2024 (€ 251,057) Unfavourable step	▼ 12%
Profit after taxes	€ 86,314 Profit after taxes 2022: € 86,314 First fiscal year in the series	€ 107,579 Profit after taxes 2023: € 107,579 ▲ 25% vs 2022 (€ 86,314) Favourable step	€ 185,606 Profit after taxes 2024: € 185,606 ▲ 73% vs 2023 (€ 107,579) Favourable step	€ 161,721 Profit after taxes 2025: € 161,721 ▼ 13% vs 2024 (€ 185,606) Unfavourable step	▼ 13%
Equity	€ 1,156,058 Equity 2022: € 1,156,058 First fiscal year in the series	€ 702,856 Equity 2023: € 702,856 ▼ 39% vs 2022 (€ 1,156,058) Unfavourable step	€ 792,261 Equity 2024: € 792,261 ▲ 13% vs 2023 (€ 702,856) Favourable step	€ 953,982 Equity 2025: € 953,982 ▲ 20% vs 2024 (€ 792,261) Favourable step	▲ 20%
Total debts	€ 7,991 Total debts 2022: € 7,991 First fiscal year in the series	€ 21,671 Total debts 2023: € 21,671 ▲ 171% vs 2022 (€ 7,991) Unfavourable step	€ 36,015 Total debts 2024: € 36,015 ▲ 66% vs 2023 (€ 21,671) Unfavourable step	€ 67,722 Total debts 2025: € 67,722 ▲ 88% vs 2024 (€ 36,015) Unfavourable step	▲ 88%
Cash	€ 278,869 Cash 2022: € 278,869 First fiscal year in the series	€ 286,524 Cash 2023: € 286,524 ▲ 3% vs 2022 (€ 278,869) Favourable step	€ 81,760 Cash 2024: € 81,760 ▼ 71% vs 2023 (€ 286,524) Unfavourable step	€ 345,283 Cash 2025: € 345,283 ▲ € 263,523 vs 2024 (€ 81,760) Favourable step	▲ € 263,523
Land & buildings	€ 8,273 Land & buildings 2022: € 8,273 First fiscal year in the series	€ 6,976 Land & buildings 2023: € 6,976 ▼ 16% vs 2022 (€ 8,273) Unchanged	€ 8,044 Land & buildings 2024: € 8,044 ▲ 15% vs 2023 (€ 6,976) Unchanged	€ 9,399 Land & buildings 2025: € 9,399 ▲ 17% vs 2024 (€ 8,044) Unchanged	▲ 17%
Retained profit	€ 1,012,258 Retained profit 2022: € 1,012,258 First fiscal year in the series	€ 559,056 Retained profit 2023: € 559,056 ▼ 45% vs 2022 (€ 1,012,258) Unfavourable step	€ 648,461 Retained profit 2024: € 648,461 ▲ 16% vs 2023 (€ 559,056) Favourable step	€ 810,182 Retained profit 2025: € 810,182 ▲ 25% vs 2024 (€ 648,461) Favourable step	▲ 25%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 560,781 Dividend 2023: € 560,781 Unchanged (€ 0) Unchanged	€ 96,201 Dividend 2024: € 96,201 ▼ 83% vs 2023 (€ 560,781) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 96,201) Unchanged	▼ 100%
Balance sheet total	€ 1,164,049 Balance sheet total 2022: € 1,164,049 First fiscal year in the series	€ 724,527 Balance sheet total 2023: € 724,527 ▼ 38% vs 2022 (€ 1,164,049) Unchanged	€ 828,276 Balance sheet total 2024: € 828,276 ▲ 14% vs 2023 (€ 724,527) Unchanged	€ 1,021,704 Balance sheet total 2025: € 1,021,704 ▲ 23% vs 2024 (€ 828,276) Unchanged	▲ 23%

Key figures of DR. FRANK VERDUYCKT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. FRANK VERDUYCKT?

What happened at DR. FRANK VERDUYCKT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 161,721 (▼ 13% vs 2024). filed late Source: NBB ↗
Sep 15, 2006 New establishment in Tongeren-Borgloon. KBO
Sep 15, 2006 New establishment in Bilzen-Hoeselt. KBO
Sep 15, 2006 Start of the company according to the CBE. KBO

In short

From € 86,314 profit in 2022 to € 161,721 profit in 2025.

Paid € 240,497 in corporate taxes since 2022.

Best year ever: 2024, with € 185,606 profit.

Paid out € 656,981 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. FRANK VERDUYCKT? We notify you, reason included.

Follow DR. FRANK VERDUYCKT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Frank Verduyckt

DR. FRANK VERDUYCKT

CVBA Kliniek voor Urologie 100%

Behind DR. FRANK VERDUYCKT is Frank Verduyckt. It owns 100% of CVBA Kliniek voor Urologie itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Frank Verduyckt

Director

Also active at: Kliniek voor Urologie

Establishments

Establishment units

Physical locations of this company

Registered office

Mantelstraat 12

3700 Tongeren-Borgloon

2.302.453.465

Hazelereik 51

3700 Tongeren-Borgloon

Active since 15 September 2006

2.302.453.564

Hospitaalstraat 15

3740 Bilzen-Hoeselt